课题基金 / 基金详情

Administrative Core

Administrative Core
行政核心
批准号:
10493720
负责人:
ELIZABETH L TRAVIS
金额:
$7.78万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-16 至 2024-08-31
关键词:

项目摘要

项目成果

ELIZABETH L TRAVIS的其他基金

相似基金

相关文献

中文摘要
翻译
行政核心项目摘要/摘要行政核心(AC)在前几个周期有效地奠定了伙伴关系的基础,并为项目的所有组成部分提供关键支持:研究、外联、教育、基础设施和专业发展。在此次更新中,AC将继续作为促进资源,在开发、实施、协调和管理伙伴关系的所有伙伴关系活动方面提供战略领导和监督,该伙伴关系的感染驱动的恶性肿瘤计划促进职业和翻译科学(IMPACT)。该核心与规划和评价以及DATAOmics核心合作,为伙伴关系的日常活动提供帮助,包括但不限于赠款管理、计划管理和会议规划,以及为成功实现伙伴关系倡议而带头进行短期和长期战略规划和确定优先顺序。在每个机构,咨询委员会由三名首席调查员和一名项目主任组成。咨询委员会的具体目标包括:1)提供领导、行政管理和组织基础设施,包括领导总体战略规划和对计划实施、评估和评估的监督;2)监督科学研究议程,以确保计划目标被明确定义并与赠款的目标保持一致,活动是深思熟虑的、计划良好的和科学合理的;3)确保核心业务高效和一体化,项目交付成果得到满足,核心和项目之间的定期沟通到位并得到促进,进度监测、结果文档和交付成果的计划目标得到满足;4)与其他U54伙伴关系以及其他内部和外部实体建立、发展和最大限度地合作,以促进可持续性;5)支持伙伴关系的项目和核心以及与内部咨询委员会(IAC)、计划指导委员会(PSC)和NCI CPACHE计划办公室的交流;6)通过制定有针对性的招聘和利用战略协作,增强UPR和UPRCCC的癌症研究能力;以及7)建立一个中央科学传播核心(SCICOM),免费向UPR和UPRCCC的教职员工和学生提供广泛的教育、编辑和出版服务。这一核心将加强PR和TX感染驱动的恶性肿瘤方面的整体癌症研究事业,并将支持UPRCCC路线图的实施,从而提交CCSG(P30)以供NCI指定为癌症中心。
英文摘要
ADMINISTRATIVE CORE PROJECT SUMMARY/ABSTRACT The Administrative Core (AC) over the previous cycles has been effective in establishing the foundation of the Partnership and providing critical support across all components of the project: research, outreach, education, infrastructure, and professional development. In this renewal, the AC will continue to serve as a facilitative resource to provide strategic leadership and oversight in the development, implementation, coordination, and management of all Partnership activities for the Partnership's Infection-Driven Malignancies Program for Advancing Careers and Translational Sciences (IMPACT). This core, which works collaboratively with the Planning and Evaluation, and DATAOmics Cores, provides assistance with the daily activities of the Partnership, including, but not limited to, grants management, program management, and meeting planning, as well as to spearhead short-term and long-term strategic planning and prioritization for the successful achievement of Partnership initiatives. At each institution, the AC is composed of three principal investigators, and one program director. Specific Aims for the AC include: 1) Provide leadership, administrative management, and organizational infrastructure, including leading overall strategic planning and oversight of program implementation, assessment and evaluation; 2) Oversee the scientific research agenda to ensure program goals are clearly defined and aligned with the goals of the grant, and that activities are thoughtful, well-planned, and scientifically sound; 3) Ensure core operations are efficient and integrated, project deliverables are met, regular communications among the cores and projects are in place and facilitated, and program goals for progress monitoring, outcomes documentation and deliverables are met; 4) Engage, develop, and maximize collaborations with other U54 Partnerships, as well as other internal and external entities to promote sustainability; 5) Support communications across the Partnership's projects and cores and with the Internal Advisory Committee (IAC), Program Steering Committee (PSC) and NCI CPACHE program office; 6) Augment the cancer research capacity of the UPR and the UPRCCC through the development of targeted hires and leveraged strategic collaborations; and 7) Establish a centralized Scientific Communication Core (SciCom) to provide a wide range of educational, editorial, and publishing services, free of charge, to UPR and UPRCCC faculty and students. This core will strengthen the overall cancer research enterprise in infection driven malignancies in PR and TX, and will support the implementation of UPRCCC's roadmap leading to the submission of a CCSG (P30) for NCI designation as a Cancer Center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research Education Core
Administrative Core
Research Education Core
Administrative Core
国内基金
海外基金
胆固醇羟化酶CH25H非酶活依赖性促进乙型肝炎病毒蛋白Core及Pre-core降解的分子机制研究
  • 批准号:
    82371765
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    谭广云
  • 依托单位:
锕系元素5f-in-core的GTH赝势和基组的开发
  • 批准号:
    22303037
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    鲁俊波
  • 依托单位:
基于合成致死策略搭建Core-matched前药共组装体克服肿瘤耐药的机制研究
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    孙丙军
  • 依托单位:
鼠伤寒沙门氏菌LPS core经由CD209/SphK1促进树突状细胞迁移加重炎症性肠病的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    叶成林
  • 依托单位: